Bipolar Disorder
📧 Sign up to get email alerts when something new happens for Bipolar Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-07-30Clinical Trial Update: Bipolarity - Depression in Children and Adolescent Suicide Attempters: Better Diagnosis to Prevent Recurrence [NA]
A completed clinical trial sponsored by Fondation Lenval evaluating improved diagnostic approaches to prevent recurrence of suicidal behavio…
-
FDA approval · 2018-07-27FDA Approved: RISPERDAL M-TAB — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA approved Janssen's supplemental application for RISPERDAL M-TAB (risperidone), resulting in updated labeling or expanded indications for…
-
CLINICAL_TRIALS trial_result · 2018-07-24Clinical Trial Update: Adjunctive Curcumin for Symptomatic Adolescents With Bipolar Disorder: Brain and Body Considerations [Phase 2]
Phase 2 trial evaluating adjunctive curcumin for symptomatic adolescents with bipolar disorder has been terminated.
-
FDA label_change · 2018-07-23FDA Approved: LAMICTAL — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for Lamictal (lamotrigine) from GlaxoSmithKline, resulting in changes to the product labeling.
-
FDA approval · 2018-07-23FDA Approved: LAMICTAL ODT — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for Lamictal ODT (lamotrigine) submitted by GlaxoSmithKline LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-07-23Clinical Trial Update: A Pilot Study on Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment of Bipolar Depression [NA]
A pilot study evaluated repetitive transcranial magnetic stimulation (rTMS) as a treatment for bipolar depression. The trial has completed a…
-
CLINICAL_TRIALS research · 2018-07-23Clinical Trial Update: Illness Representations in Patients With Bipolar Disorders
Clinical trial update concerning illness representations in patients with bipolar disorder.
-
CLINICAL_TRIALS withdrawal · 2018-07-20Clinical Trial Update: Open-Label Study of Latuda for the Treatment of Mania in Children and Adolescents 6-17 Years Old [Phase 4]
Open-label Phase 4 study of lurasidone (Latuda) for mania in youths aged 6-17 was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2018-07-18Clinical Trial Update: Prevention of Weight Gain and Dyslipidemia by Green Tea in Patients Initiating Therapy With Olanzapine [NA]
A clinical trial investigating whether green tea can prevent olanzapine-associated weight gain and dyslipidemia in patients with bipolar dis…
-
CLINICAL_TRIALS trial_result · 2018-07-17Clinical Trial Update: Treatment of Mania Symptoms With Drug Therapy [Phase 3]
A Phase 3 trial update announcing completion and posting of results for a drug therapy aimed at treating mania symptoms in bipolar Disorder …
-
CLINICAL_TRIALS trial_result · 2018-07-17Clinical Trial Update: Quantified Mobile Sensing for Improving Diagnosis and Measuring Disease Progression
A completed clinical trial update reports results on using quantified mobile sensing to improve diagnosis and measure disease progression in…
-
CLINICAL_TRIALS trial_result · 2018-07-13Clinical Trial Update: Berlin Magnetic Seizure Therapy Depression Trial 01 [Phase 3]
A Phase 3 clinical trial of Berlin Magnetic Seizure Therapy for major depressive disorder and bipolar disorder has completed.
-
CLINICAL_TRIALS research · 2018-07-13Clinical Trial Update: Micronutrients as Adjunctive Treatment for Bipolar Disorder [NA]
This ClinicalTrials.gov update notes a study evaluating micronutrients as adjunctive treatment for Bipolar Disorder, with the current status…
-
CLINICAL_TRIALS trial_result · 2018-07-05Clinical Trial Update: Examination of Brain Serotonin Receptors in Patients With Mood Disorders
A completed clinical trial sponsored by the National Institute of Mental Health studied brain serotonin receptors in individuals with mood d…
-
FDA approval · 2018-07-03FDA Approved: OLANZAPINE — Original Application (HEC Pharm USA Inc.)
FDA approved the original Abbreviated New Drug Application for olanzapine (generic) submitted by HEC Pharm USA Inc. The approval enables a g…
-
FDA approval · 2018-06-27FDA Approved: LAMICTAL — Supplemental Application (GlaxoSmithKline LLC)
The FDA approved a supplemental application for Lamictal (lamotrigine) submitted by GlaxoSmithKline LLC to update the product labeling.
-
FDA approval · 2018-06-27FDA Approved: LAMICTAL ODT — Supplemental Application (GlaxoSmithKline LLC)
The FDA approved a supplemental application for LAMICTAL ODT (lamotrigine) from GlaxoSmithKline LLC. The approval updates the labeling for t…
-
CLINICAL_TRIALS trial_result · 2018-06-19Clinical Trial Update: Vitamin D Supplementation for Bipolar Depression [NA]
This entry reports the completion and posting of results for a clinical trial evaluating vitamin D supplementation in individuals with bipol…
-
CLINICAL_TRIALS trial_result · 2018-06-15Clinical Trial Update: Metabolic Effects of Antipsychotics in Children [Phase 4]
Phase 4 pediatric trial evaluating the metabolic effects of antipsychotics; results have been posted following completion.
-
CLINICAL_TRIALS trial_result · 2018-06-15Clinical Trial Update: Improving Representative Payeeship for People With Psychiatric Disabilities and Their Families [NA]
A clinical trial examining how to improve representative payeeship for people with psychiatric disabilities and their families has completed…
-
CLINICAL_TRIALS trial_result · 2018-06-14Clinical Trial Update: Risperidone Plus Mood Stabilizer in Treatment of Mixed Mania [Phase 4]
A Phase 4 trial evaluating risperidone plus a mood stabilizer for treating mixed mania in bipolar disorder has completed.
-
CLINICAL_TRIALS trial_result · 2018-06-12Clinical Trial Update: Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders [Phase 1]
Phase 1 trial update evaluating pharmacokinetics, safety, and tolerability of oral brexpiprazole in children 6 to <13 with CNS disorders; st…
-
CLINICAL_TRIALS trial_result · 2018-06-04Clinical Trial Update: Exercise and Cognitive Training [NA]
A clinical trial evaluating exercise and cognitive training for schizophrenia, schizoaffective disorder, and bipolar disorder has completed.
-
CLINICAL_TRIALS research · 2018-05-29Clinical Trial Update: Smartphone-based Ambulatory Assessment of Early Warning Signs [NA]
This entry reports an update on a clinical trial evaluating smartphone-based ambulatory assessment for early warning signs in bipolar disord…
-
CLINICAL_TRIALS trial_result · 2018-05-23Clinical Trial Update: Exploratory Trial to Assess the Functionality of an Integrated Call Center for the Digital Medicine System [Phase 2]
This document reports the completed Phase 2 exploratory trial evaluating the functionality of an integrated call center for a digital medici…